Entrada Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Entrada Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Entrada Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 37.2M shares, a 11.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 37.2M +3.97M +11.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.6M +470K +1.42% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 33.4M +2.04M +6.51% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 33.3M +2.01M +6.43% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 33.2M +1.92M +6.14% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 33.1M +1.87M +5.98% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 31.4M +170K +0.55% Dec 31, 2022 10-K 2024-03-13
Q3 2022 31.3M +29.8M +1924% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 31.3M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 31.3M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 31.2M +30M +2410% Dec 31, 2021 10-K 2023-03-06
Q3 2021 1.55M Sep 30, 2021 10-Q 2021-12-09
Q4 2020 1.24M Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.